Advanced in REM Behavior Disorder

Brit Mollenhauer

Robert Koch Str. 40, 
Goettingen, NI, DE 
Advanced in REM Behavior Disorder
Robert Koch Str. 40, 
Goettingen, NI, DE 
OverviewLocationsClinical Research

Overview

Brit Mollenhauer practices in Goettingen, Germany. Mr. Mollenhauer is rated as an Advanced expert by MediFind in the treatment of REM Behavior Disorder. His top areas of expertise are Parkinson's Disease, Movement Disorders, Dementia, Tissue Biopsy, and Deep Brain Stimulation.

His clinical research consists of co-authoring 289 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of REM Behavior Disorder.

Gender
Male

Locations

Robert Koch Str. 40, Goettingen, NI 37075, Germany
Other Locations
Von Siebold Str. 5, 37075 Göttingen, Hermann Rein Str. 3, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease
Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease
Enrollment Status: Completed
Publish Date: January 29, 2024
Intervention Type: Other
Study Phase: Not Applicable
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
View 1 Less Clinical Trial

288 Total Publications

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.
Journal: Journal of Parkinson's disease
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mollenhauer's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile